ALPH — AlphaHelix Molecular Diagnostics AB (publ) Share Price
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro CapNeutral
- SEK46.28m
- SEK40.09m
- SEK34.68m
- 53
- 28
- 13
- 20
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.39 | ||
| Price to Tang. Book | 3.71 | ||
| Price to Free Cashflow | 17.95 | ||
| Price to Sales | 1.55 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -21.38% | ||
| Return on Equity | -19.59% | ||
| Operating Margin | -14.42% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 18.3 | 17.19 | 23.71 | 44.65 | 34.68 | n/a | n/a | 8.09% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | +209.67 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Alphahelix Molecular Diagnostics publ AB is a Sweden-based company engaged in the development, manufacture and marketing of technology and products for the identification and quantitation of deoxyribonucleic acid (DNA) in molecular diagnostics and life science research. Its product portfolio utilizes polymerase chain reaction (PCR) and is based on the SuperConvection technology, which speeds up thermal cycling and increases temperature homogenization. The Company’s primary product portfolio includes Alpha Amp, a thermal cycler utilizing SuperConvention technology; Alpha Bot, a pipetting robot focused on the automatic set of PCR reactions for the research and clinical activities. The Company’s products can be utilized with DNA analysis in the fields of veterinary diagnostics, forensic DNA analysis, food pathogen detection and biosafety analyses.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- March 31st, 2023
- Incorporated
- January 1st, 1970
- Public Since
- September 15th, 2006
- No. of Employees
- 8
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- AktieTorget Stock Exchange
- Shares in Issue
- 63,398,901
- Address
- Fannys Vag 5, NACKA, 131 54
- Web
- http://www.alphahelix.com
- Phone
- +46 18120701
- Auditors
- Baker Tilly Sverige AB
Upcoming Events for ALPH
Similar to ALPH
Alteco Medical AB
AktieTorget Stock Exchange
Audientes A/S
AktieTorget Stock Exchange
BibbInstruments AB
AktieTorget Stock Exchange
Calmark Sweden AB
AktieTorget Stock Exchange
Calmark Sweden AB
AktieTorget Stock Exchange
FAQ
What is the AlphaHelix Molecular Diagnostics AB (publ) share price?
As of Today at 07:00 UTC, shares in AlphaHelix Molecular Diagnostics AB (publ) are trading at SEK0.73. This share price information is delayed by 15 minutes.
How has the AlphaHelix Molecular Diagnostics AB (publ) share price performed this year?
Shares in AlphaHelix Molecular Diagnostics AB (publ) last closed at SEK0.73 and the price had moved by -33.64% over the past 365 days. In terms of relative price strength the AlphaHelix Molecular Diagnostics AB (publ) share price has underperformed the FTSE Global All Cap Index by -36.21% over the past year.
What are the analyst and broker recommendations for AlphaHelix Molecular Diagnostics AB (publ)?
There is no consensus recommendation for this security.
What is the AlphaHelix Molecular Diagnostics AB (publ) dividend yield?
AlphaHelix Molecular Diagnostics AB (publ) does not currently pay a dividend.
Does AlphaHelix Molecular Diagnostics AB (publ) pay a dividend?
AlphaHelix Molecular Diagnostics AB (publ) does not currently pay a dividend.
When does AlphaHelix Molecular Diagnostics AB (publ) next pay dividends?
AlphaHelix Molecular Diagnostics AB (publ) does not currently pay a dividend.
How do I buy AlphaHelix Molecular Diagnostics AB (publ) shares?
To buy shares in AlphaHelix Molecular Diagnostics AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of AlphaHelix Molecular Diagnostics AB (publ)?
As of the previous close price of SEK0.73, shares in AlphaHelix Molecular Diagnostics AB (publ) had a market capitalisation of SEK46.28m.
Where are AlphaHelix Molecular Diagnostics AB (publ) shares listed?
Here are the trading details for AlphaHelix Molecular Diagnostics AB (publ):
- Country of listing: Sweden
- Exchange: AKT
- Ticker Symbol: ALPH
What kind of share is AlphaHelix Molecular Diagnostics AB (publ)?
Based on an overall assessment of its quality, value and momentum AlphaHelix Molecular Diagnostics AB (publ) is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a AlphaHelix Molecular Diagnostics AB (publ) share price forecast for 2023?
We could not find analyst target price data for this security.
What is the trend in the AlphaHelix Molecular Diagnostics AB (publ) share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AlphaHelix Molecular Diagnostics AB (publ). Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +3.09%.
As of the last closing price of SEK0.73, shares in AlphaHelix Molecular Diagnostics AB (publ) were trading +6.27% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the AlphaHelix Molecular Diagnostics AB (publ) PE Ratio?
The AlphaHelix Molecular Diagnostics AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.73.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of AlphaHelix Molecular Diagnostics AB (publ)?
AlphaHelix Molecular Diagnostics AB (publ)'s management team is headed by:
- Mikael Havsjo - CHM
- Mattias Molin - PRE
- Ulrica Karlsson - CFO
- Artur Aira - DRC